Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Elnaz Khani"'
Autor:
Naser Aslanabadi, Elnaz Khani, Sajad Khiali, Haleh Rezaee, Saba Pishdad, Taher Entezari-Maleki
Publikováno v:
Pharmaceutical Sciences, Vol 30, Iss 1, Pp 129-134 (2024)
Background: Periprocedural myocardial injury (PMI) after percutaneous coronary intervention (PCI) is a substantial health issue with a high mortality rate. Inflammation and oxidative stress are major contributing factors to PMI. Allopurinol inhibits
Externí odkaz:
https://doaj.org/article/5b673c97321949f5ad16b3ccfeedf423
Publikováno v:
Clinical Case Reports, Vol 12, Iss 2, Pp n/a-n/a (2024)
Key Clinical Message While reports of new‐onset systemic lupus erythematosus (SLE) after mRNA‐based COVID‐19 vaccines exist, no such reports have been documented following inactivated vaccines. We describe a case of SLE after receiving the BBIB
Externí odkaz:
https://doaj.org/article/48a93df90682431eba0af8fd387e8f1f
Publikováno v:
Journal of Pharmaceutical Care, Vol 11, Iss 1 (2023)
Background: Effective clinical care and identifying susceptibility to COVID-19-related mortality requires rapid recognition of risk factors and their relations with disease outcomes. This study aimed to cluster and identify various subgroups of COVID
Externí odkaz:
https://doaj.org/article/b7104cb93230411eb62e886852266ab1
Autor:
Elnaz Khani, Manouchehr Khoshbaten, Fariba Pourkarim, Mohammad Asghari Jafarabadi, Elnaz Shaseb
Publikováno v:
Journal of Pharmaceutical Care, Vol 10, Iss 4 (2022)
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the important health issues with high prevalence worldwide. However, there is no approved medication for that. As one of the indicators of metabolic syndrome, uric acid might play a role
Externí odkaz:
https://doaj.org/article/658c3d3adf25411ba82e241c1ee2dd9c
Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic
Publikováno v:
Future Microbiology. 17:377-391
Despite the progress in the management of COVID-19, effective oral antiviral agents are still lacking. In the present review, the potential beneficial effects of molnupiravir in the management of COVID-19 are discussed. A literature search in Google
Publikováno v:
Archives of Virology. 167:751-805
In the current pandemic of coronavirus disease 2019 (COVID-19), antiviral drugs are at the center of attention because of their critical role against severe acute respiratory disease syndrome coronavirus 2 (SARS-CoV-2). In addition to designing new a
Autor:
Naser Aslanabadi, Elnaz Khani, Sajad Khiali, Haleh Rezaee, Saba Pishdad, Taher Entezari-Maleki
Publikováno v:
Pharmaceutical Sciences.
Background: Periprocedural myocardial injury (PMI) after percutaneous coronary intervention (PCI) is a substantial health issue with a high mortality rate. Inflammation and oxidative stress are major contributing factors to PMI. Allopurinol inhibits
Autor:
Elnaz Khani, Manouchehr Khoshbaten, Fariba Pourkarim, Mohammad Asghari Jafarabadi, Elnaz Shaseb
Publikováno v:
Journal of Pharmaceutical Care.
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the important health issues with high prevalence worldwide. However, there is no approved medication for that. As one of the indicators of metabolic syndrome, uric acid might play a role
Publikováno v:
Journal of Medical Virology. 95
As of September 11, 2022, 57 669 reports of monkeypox infection raised global concern. Previous vaccinia virus vaccination can protect from monkeypox. However, after smallpox eradication, immunization against that was stopped. Indeed, therapeutic opt
Autor:
Elnaz Khani, Taher Entezari-Maleki
Publikováno v:
International Journal of Surgery. 109:75-76